JP2022545782A5 - - Google Patents
Info
- Publication number
- JP2022545782A5 JP2022545782A5 JP2022510801A JP2022510801A JP2022545782A5 JP 2022545782 A5 JP2022545782 A5 JP 2022545782A5 JP 2022510801 A JP2022510801 A JP 2022510801A JP 2022510801 A JP2022510801 A JP 2022510801A JP 2022545782 A5 JP2022545782 A5 JP 2022545782A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- induction medium
- population
- mesoderm
- differentiation factors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1911957.7A GB201911957D0 (en) | 2019-08-20 | 2019-08-20 | Methods of producing haemogenic progenitor cells from pluripotent stem cells |
| GB1911957.7 | 2019-08-20 | ||
| PCT/EP2020/073396 WO2021032851A1 (en) | 2019-08-20 | 2020-08-20 | Methods of producing haemogenic progenitor cells from pluripotent stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545782A JP2022545782A (ja) | 2022-10-31 |
| JP2022545782A5 true JP2022545782A5 (https=) | 2023-08-18 |
Family
ID=68099409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510801A Pending JP2022545782A (ja) | 2019-08-20 | 2020-08-20 | 多能性幹細胞から造血性前駆細胞を生産する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220267733A1 (https=) |
| EP (1) | EP4017967A1 (https=) |
| JP (1) | JP2022545782A (https=) |
| KR (1) | KR20220049032A (https=) |
| CN (1) | CN114269906A (https=) |
| AU (1) | AU2020332863A1 (https=) |
| BR (1) | BR112022003089A2 (https=) |
| CA (1) | CA3150427A1 (https=) |
| GB (1) | GB201911957D0 (https=) |
| IL (1) | IL290605A (https=) |
| MX (1) | MX2022001960A (https=) |
| WO (1) | WO2021032851A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11459372B2 (en) | 2020-11-30 | 2022-10-04 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
| WO2022144632A1 (en) | 2020-12-30 | 2022-07-07 | Crispr Therapeutics Ag | Compositions and methods for differentiating stem cells into nk cells |
| GB202102297D0 (en) * | 2021-02-18 | 2021-04-07 | Adaptimmune Ltd | Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells |
| CN113046318B (zh) * | 2021-04-13 | 2023-04-18 | 中国科学院深圳先进技术研究院 | 一种诱导多能干细胞向造血前体细胞分化的培养基以及方法 |
| EP4326852A4 (en) * | 2021-04-22 | 2025-04-23 | Artec Biotech, Inc. | Method for producing hematopoietic cells from stem cells using vascular organoids |
| CN113265377B (zh) * | 2021-06-11 | 2023-01-24 | 中国医学科学院血液病医院(中国医学科学院血液学研究所) | 一种动脉内皮促进功能性t细胞再生的方法 |
| WO2023038436A1 (ko) * | 2021-09-10 | 2023-03-16 | 의료법인 성광의료재단 | 전분화능 줄기세포 유래 조혈모세포 제조방법 및 상기 제조된 조혈모세포를 이용한 인간화 마우스 모델 제작방법 |
| CN116410927A (zh) * | 2021-12-31 | 2023-07-11 | 士泽生物医药(苏州)有限公司 | 干细胞诱导分化为造血祖细胞的方法 |
| CN116376822A (zh) * | 2021-12-31 | 2023-07-04 | 北京大学 | 利用人多潜能干细胞体外制备t淋巴细胞 |
| TW202340453A (zh) * | 2022-01-28 | 2023-10-16 | 中國大陸商杭州啟函生物科技有限公司 | 用於基於細胞的免疫療法的方法和組合物 |
| GB202205572D0 (en) | 2022-04-14 | 2022-06-01 | Adaptimmune Ltd | Engineered T cells |
| GB202208545D0 (en) | 2022-06-10 | 2022-07-27 | Adaptimmune Ltd | Production of immune cells |
| CN114958771B (zh) * | 2022-06-27 | 2023-12-05 | 广东康盾创新产业集团股份公司 | 一种ipsc-car-nk细胞的制备方法 |
| CN115247151B (zh) * | 2022-09-21 | 2022-12-27 | 呈诺再生医学科技(北京)有限公司 | 制备造血内皮细胞的方法及制备造血干细胞或造血干祖细胞的方法 |
| KR20240054468A (ko) * | 2022-10-18 | 2024-04-26 | 의료법인 성광의료재단 | 줄기세포에서 대식세포로의 분화 유도용 배지 조성물 및 이를 이용한 분화 방법 |
| AU2022489613A1 (en) * | 2022-12-02 | 2025-07-10 | Nuwacell Biotechnologies Co., Ltd. | Methods and compositions for differentiation of pluripotent stem cells and derived natural killer cells |
| CN117264888A (zh) * | 2023-10-11 | 2023-12-22 | 苏州艾凯利元生物科技有限公司 | 一种制备造血干细胞和祖细胞的方法 |
| GB202318950D0 (en) | 2023-12-12 | 2024-01-24 | Adaptimmune Ltd | Production of immune cells |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008151390A1 (en) * | 2007-06-15 | 2008-12-18 | Australian Stem Cell Centre Ltd | Differentiation of human embryonic stem cells |
| US8652845B2 (en) * | 2010-03-18 | 2014-02-18 | Kyoto University | Method for producing mesodermal cells by culturing under adherent conditions and without co-culture with cells from a different species in a serum-free medium |
| HUE043785T2 (hu) * | 2013-03-13 | 2019-09-30 | Wisconsin Alumni Res Found | Módszerek és anyagok humán pluripotens õssejtek hematoendothelialis differenciálására meghatározott körülmények között |
| US10385313B2 (en) * | 2013-10-01 | 2019-08-20 | The Usa, As Represented By The Secretary, Department Of Health And Human Services | Human IPSC-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings |
| WO2016123100A1 (en) * | 2015-01-26 | 2016-08-04 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| SG11201706706XA (en) * | 2015-02-20 | 2017-09-28 | Wisconsin Alumni Res Found | Generating arterial endothelial cell populations |
| KR20250141836A (ko) * | 2015-11-04 | 2025-09-29 | 페이트 세러퓨틱스, 인코포레이티드 | 만능 세포의 유전자 조작 |
| SG11201803145RA (en) * | 2015-11-04 | 2018-05-30 | Fate Therapeutics Inc | Methods and compositions for inducing hematopoietic cell differentiation |
| US11261430B2 (en) * | 2016-05-03 | 2022-03-01 | The Children's Medical Center Corporation | Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells |
| EP3621630A4 (en) * | 2017-06-14 | 2021-03-10 | The Children's Medical Center | HEMATOPOIETIC STEM AND PRECURSOR CELLS FROM HEMOGENIC ENDOTHELIAL CELLS BY EPISOMAL PLASMID GENERAL TRANSFER |
| CN112041428B (zh) * | 2018-01-18 | 2024-05-24 | 新加坡科技研究局 | 用于在悬浮培养物中分化人多能干细胞系的方法 |
| GB202006903D0 (en) * | 2020-05-11 | 2020-06-24 | Adaptimmune Ltd | Modified iPSCs |
-
2019
- 2019-08-20 GB GBGB1911957.7A patent/GB201911957D0/en not_active Ceased
-
2020
- 2020-08-20 WO PCT/EP2020/073396 patent/WO2021032851A1/en not_active Ceased
- 2020-08-20 CN CN202080059222.4A patent/CN114269906A/zh active Pending
- 2020-08-20 EP EP20761193.0A patent/EP4017967A1/en active Pending
- 2020-08-20 JP JP2022510801A patent/JP2022545782A/ja active Pending
- 2020-08-20 AU AU2020332863A patent/AU2020332863A1/en not_active Abandoned
- 2020-08-20 KR KR1020227009012A patent/KR20220049032A/ko active Pending
- 2020-08-20 BR BR112022003089A patent/BR112022003089A2/pt unknown
- 2020-08-20 MX MX2022001960A patent/MX2022001960A/es unknown
- 2020-08-20 CA CA3150427A patent/CA3150427A1/en active Pending
- 2020-08-20 US US17/630,882 patent/US20220267733A1/en active Pending
-
2022
- 2022-02-14 IL IL290605A patent/IL290605A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022545782A5 (https=) | ||
| JP2022545415A5 (https=) | ||
| US12241087B2 (en) | Compositions and methods for differentiating stem cells into NK cells | |
| JP7061961B2 (ja) | 多能性幹細胞の免疫細胞への分化を誘導する方法 | |
| JP6344821B2 (ja) | 造血前駆体の集団および造血前駆体のための幹細胞を富化する方法 | |
| JP7212615B2 (ja) | 多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法 | |
| US9771561B2 (en) | Method of making primate cells expressing apelin receptor that have mesangioblast potential | |
| JP2024507472A5 (https=) | ||
| JP2022545078A5 (https=) | ||
| CN103003416A (zh) | 从小体积的外周血产生诱导性多潜能干细胞 | |
| Netsrithong et al. | Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation | |
| CN107429230A (zh) | 用于诱导造血细胞分化的方法和组合物 | |
| CA2905786A1 (en) | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions | |
| IL305018A (en) | Methods of producing haemogenic endothelial cells from pluripotent stem cells | |
| Galić et al. | Generation of T lineage cells from human embryonic stem cells in a feeder free system | |
| JP2022545416A5 (https=) | ||
| Liu et al. | Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells | |
| Lu et al. | Enhanced generation of hematopoietic cells from human hepatocarcinoma cell− stimulated human embryonic and induced pluripotent stem cells | |
| Philonenko et al. | Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines | |
| Gong et al. | Interplay of transcription factors and microRNAs during embryonic hematopoiesis | |
| Lee et al. | Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells | |
| CN115087732B (zh) | 来自人T细胞来源的iPS细胞的细胞毒性T细胞 | |
| Wilkinson et al. | Expanded potential stem cell media as a tool to study human developmental hematopoiesis in vitro | |
| Wang | Endothelial and hematopoietic cell fate of human embryonic stem cells | |
| WO2023233339A1 (en) | Compositions and methods for differentiating stem cells into nk cells |